Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Jankovic

Showing results (21-30 of 243) with videos related to

Pageof 25
Sort By:
Disease Markers|March 2, 2012
Assessment of sialic acid diversity in cancer- and non-cancer related CA125 antigen using sialic acid-binding Ig-like lectins (Siglecs)N Mitic, B Milutinovic, M Jankovic
Methods and Findings in Experimental and Clinical Pharmacology|January 18, 2008
Pharmacokinetic modeling of valproate from clinical data in Serbian epileptic patientsS M Jankovic, J R Milovanovic
International Journal of Clinical Pharmacology and Therapeutics|June 22, 2023
Factors affecting outcome in hospitalized patients treated according to recommendations from clinical pharmacologistsMarko M Folic, Slobodan M Jankovic
European Journal of Clinical Pharmacology|May 17, 2011
Knowledge of the pharmacological profile of a patient improves the quality of prescribing, the outcomes of treatment, and the utilization of health services in primary health careSrdjan M Stefanovic, Slobodan M Jankovic
Minerva Pediatrica|November 1, 1994
[Brucellosis in childhood: therapeutic contribution]G Conte, D Bacchiocchi, M Jankovic
Experimental and Clinical Cardiology|July 25, 2008
Cost and utility of a low-molecular-weight heparin and unfractionated heparin for treatment of deep venous thrombosis in a Balkan country: A model analysisSlobodan M Jankovic, Dragan R Milovanovic
Molecular Human Reproduction|April 24, 2007
Pregnancy-associated CA125 antigen as mucin: evaluation of ferning morphologyM M Jankovic, B S Milutinovic
Texas Heart Institute Journal|August 6, 2013
Alexander I. Ignatowski: a pioneer in the study of atherosclerosisIgor E Konstantinov, Gradimir M Jankovic
Expert Opinion on Drug Metabolism & Toxicology|December 3, 2014
Is bioavailability altered in generic versus brand anticonvulsants?Slobodan M Jankovic, Dragana Ignjatovic Ristic
The Journal of Antibiotics|November 21, 2013
Inverse correlation of Acinetobacter spp. resistance rate and ciprofloxacin utilizationRadisa R Pavlovic, Slobodan M Jankovic
Pageof 25

Showing results (21-30 of 243) with videos related to

Sort By:
Pageof 25
Disease Markers|March 2, 2012
Assessment of sialic acid diversity in cancer- and non-cancer related CA125 antigen using sialic acid-binding Ig-like lectins (Siglecs)N Mitic, B Milutinovic, M Jankovic
Methods and Findings in Experimental and Clinical Pharmacology|January 18, 2008
Pharmacokinetic modeling of valproate from clinical data in Serbian epileptic patientsS M Jankovic, J R Milovanovic
International Journal of Clinical Pharmacology and Therapeutics|June 22, 2023
Factors affecting outcome in hospitalized patients treated according to recommendations from clinical pharmacologistsMarko M Folic, Slobodan M Jankovic
European Journal of Clinical Pharmacology|May 17, 2011
Knowledge of the pharmacological profile of a patient improves the quality of prescribing, the outcomes of treatment, and the utilization of health services in primary health careSrdjan M Stefanovic, Slobodan M Jankovic
Minerva Pediatrica|November 1, 1994
[Brucellosis in childhood: therapeutic contribution]G Conte, D Bacchiocchi, M Jankovic
Experimental and Clinical Cardiology|July 25, 2008
Cost and utility of a low-molecular-weight heparin and unfractionated heparin for treatment of deep venous thrombosis in a Balkan country: A model analysisSlobodan M Jankovic, Dragan R Milovanovic
Molecular Human Reproduction|April 24, 2007
Pregnancy-associated CA125 antigen as mucin: evaluation of ferning morphologyM M Jankovic, B S Milutinovic
Texas Heart Institute Journal|August 6, 2013
Alexander I. Ignatowski: a pioneer in the study of atherosclerosisIgor E Konstantinov, Gradimir M Jankovic
Expert Opinion on Drug Metabolism & Toxicology|December 3, 2014
Is bioavailability altered in generic versus brand anticonvulsants?Slobodan M Jankovic, Dragana Ignjatovic Ristic
The Journal of Antibiotics|November 21, 2013
Inverse correlation of Acinetobacter spp. resistance rate and ciprofloxacin utilizationRadisa R Pavlovic, Slobodan M Jankovic
Pageof 25